JP MORGAN CHASE & CO. news, videos and press releases - Page 3
For more news please use our advanced search feature.
JP MORGAN CHASE & CO. - More news...
JP MORGAN CHASE & CO. - More news...
- Akeso to Share Global Strategy for New Drug Development at the 43rd J.P. Morgan Healthcare Conference
- Danaher to Present at J.P. Morgan Healthcare Conference
- Waystar to Present at J.P. Morgan Healthcare Conference
- Nuvation Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference
- Mirum Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
- J.P. Morgan Asset Management Strengthens Retirement Business with Strategic Hires
- Genprex to Participate at the 43rd Annual J.P. Morgan Healthcare Conference
- Avanos Medical, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference
- Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 8th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2025”
- Sera Prognostics to Present at 43rd Annual J.P. Morgan Healthcare Conference
- Leap Therapeutics to Participate at the 43rd Annual J.P. Morgan Healthcare Conference
- Merck to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
- NUTEX HEALTH TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
- Innovent to Participate and Present at the 43rd Annual J.P. Morgan Healthcare Conference
- Innovent to Participate and Present at the 43rd Annual J.P. Morgan Healthcare Conference
- Avantor® to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
- Quanterix to Present at the 43rd Annual J.P. Morgan Healthcare Conference
- CONMED Corporation to Present at the J.P. Morgan Healthcare Conference
- 10x Genomics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
- Guardant Health to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
- Alkermes to Present at the 43rd Annual J.P. Morgan Healthcare Conference
- Alkermes to Present at the 43rd Annual J.P. Morgan Healthcare Conference
- Rocket Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
- OS Therapies to Attend the 43rd Annual J.P. Morgan Healthcare Conference
- Boston Scientific Announces Participation in the J.P. Morgan Healthcare Conference and Conference Call Discussing Fourth Quarter 2024 Results
- Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
- JPMorgan Announces Final Cash Distributions for the JPMorgan ETFs
- Bridge Biotherapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
- Ascentage Pharma to Present at 43rd Annual J.P. Morgan Healthcare Conference
- Ascentage Pharma to Present at 43rd Annual J.P. Morgan Healthcare Conference
